Search research articles
Contact Us
Filters
Showing results (1-10 of 70) with videos related to
Page
of 7
Sort By:
Current Pharmaceutical Design
|
September 17, 2009
Antioxidant effects of natural bioactive compounds
Clara Balsano, Anna Alisi
Current Opinion in Endocrinology, Diabetes, and Obesity
|
December 10, 2019
Gastrointestinal peptides and nonalcoholic fatty liver disease
Giovanni Tarantino, Clara Balsano
Current Medicinal Chemistry
|
May 14, 2008
Viral hepatitis B: established and emerging therapies
Clara Balsano, Anna Alisi
Current Drug Targets
|
June 13, 2009
Liver fibrosis and therapeutic strategies: the goal for improving metabolism
Clara Balsano, Anna Alisi, Valerio Nobili
Annals of Translational Medicine
|
May 13, 2020
Bridging the "last mile" gap between AI implementation and operation: "data awareness" that matters
Federico Cabitza, Andrea Campagner, Clara Balsano
Expert Review of Gastroenterology & Hepatology
|
April 21, 2021
Liver-spleen axis in nonalcoholic fatty liver disease
Giovanni Tarantino, Vincenzo Citro, Clara Balsano
Biomed Research International
|
April 19, 2014
MicroRNAs in nonalcoholic fatty liver disease: novel biomarkers and prognostic tools during the transition from steatosis to hepatocarcinoma
Manuele Gori, Mario Arciello, Clara Balsano
Metallomics : Integrated Biometal Science
|
October 20, 2018
Is copper a new target to counteract the progression of chronic diseases?
Clara Balsano, Cristiana Porcu, Silvia Sideri
Oxidative Medicine and Cellular Longevity
|
December 28, 2013
Mitochondrial dysfunctions and altered metals homeostasis: new weapons to counteract HCV-related oxidative stress
Mario Arciello, Manuele Gori, Clara Balsano
The Journal of Biological Chemistry
|
February 1, 2006
Role of p38 MAPK and RNA-dependent protein kinase (PKR) in hepatitis C virus core-dependent nuclear delocalization of cyclin B1
Alessandra Spaziani, Anna Alisi, Donatella Sanna, et al.
Page
of 7
Search research articles
Search
Showing results (1-10 of 70) with videos related to
Sort By:
Page
of 7
Current Pharmaceutical Design
|
September 17, 2009
Antioxidant effects of natural bioactive compounds
Clara Balsano, Anna Alisi
Current Opinion in Endocrinology, Diabetes, and Obesity
|
December 10, 2019
Gastrointestinal peptides and nonalcoholic fatty liver disease
Giovanni Tarantino, Clara Balsano
Current Medicinal Chemistry
|
May 14, 2008
Viral hepatitis B: established and emerging therapies
Clara Balsano, Anna Alisi
Current Drug Targets
|
June 13, 2009
Liver fibrosis and therapeutic strategies: the goal for improving metabolism
Clara Balsano, Anna Alisi, Valerio Nobili
Annals of Translational Medicine
|
May 13, 2020
Bridging the "last mile" gap between AI implementation and operation: "data awareness" that matters
Federico Cabitza, Andrea Campagner, Clara Balsano
Expert Review of Gastroenterology & Hepatology
|
April 21, 2021
Liver-spleen axis in nonalcoholic fatty liver disease
Giovanni Tarantino, Vincenzo Citro, Clara Balsano
Biomed Research International
|
April 19, 2014
MicroRNAs in nonalcoholic fatty liver disease: novel biomarkers and prognostic tools during the transition from steatosis to hepatocarcinoma
Manuele Gori, Mario Arciello, Clara Balsano
Metallomics : Integrated Biometal Science
|
October 20, 2018
Is copper a new target to counteract the progression of chronic diseases?
Clara Balsano, Cristiana Porcu, Silvia Sideri
Oxidative Medicine and Cellular Longevity
|
December 28, 2013
Mitochondrial dysfunctions and altered metals homeostasis: new weapons to counteract HCV-related oxidative stress
Mario Arciello, Manuele Gori, Clara Balsano
The Journal of Biological Chemistry
|
February 1, 2006
Role of p38 MAPK and RNA-dependent protein kinase (PKR) in hepatitis C virus core-dependent nuclear delocalization of cyclin B1
Alessandra Spaziani, Anna Alisi, Donatella Sanna, et al.
Page
of 7